Chordoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{Chordoma}} | {{Chordoma}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | |||
There are no drugs currently approved to treat chordoma, however chordoma has been shown to have a limited response to the [[PDGFR]] inhibitor [[Imatinib]].<ref name="pmid15372471">{{cite journal |author=Casali PG, Messina A, Stacchiotti S, ''et al'' |title=Imatinib mesylate in chordoma |journal=Cancer |volume=101 |issue=9 |pages=2086-97 |year=2004 |pmid=15372471 |doi=10.1002/cncr.20618}}</ref> | There are no drugs currently approved to treat chordoma, however chordoma has been shown to have a limited response to the [[PDGFR]] inhibitor [[Imatinib]].<ref name="pmid15372471">{{cite journal |author=Casali PG, Messina A, Stacchiotti S, ''et al'' |title=Imatinib mesylate in chordoma |journal=Cancer |volume=101 |issue=9 |pages=2086-97 |year=2004 |pmid=15372471 |doi=10.1002/cncr.20618}}</ref> | ||
| Line 11: | Line 15: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Needs content]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 14:05, 11 September 2012
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Chordoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chordoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Chordoma medical therapy |
|
Risk calculators and risk factors for Chordoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
There are no drugs currently approved to treat chordoma, however chordoma has been shown to have a limited response to the PDGFR inhibitor Imatinib.[1]
References
- ↑ Casali PG, Messina A, Stacchiotti S; et al. (2004). "Imatinib mesylate in chordoma". Cancer. 101 (9): 2086–97. doi:10.1002/cncr.20618. PMID 15372471.